Erlotinib Plus Chemotherapy for Treatment of Triple Negative Breast Cancer
Clinical trial NCT00491816 · UNKNOWN
Trial details
- NCT number
- NCT00491816
- Sponsor
- University of Kansas Medical Center
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-07-01
- Primary completion
- 2014-12-01
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.